{"title":"颈动脉支架置入术围手术期缺血性心脏病的预防策略。","authors":"Shinya Fukuta, Mitsuhiro Iwasaki, Hidekazu Yamazaki, Masahiro Maeda, Masaki Koh, Yasufumi Inaka, Hiroaki Sato, Taichiro Hayase, Masafumi Morimoto","doi":"10.5797/jnet.oa.2023-0062","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>We have been performing preoperative coronary artery assessments and implementing coronary revascularization or intraoperative adjunctive therapies as needed in patients scheduled for carotid artery stenting (CAS) to prevent ischemic heart disease. In this study, we report the results of a retrospective observation of patients who underwent CAS under our treatment strategy to prevent perioperative coronary ischemic complications.</p><p><strong>Methods: </strong>A total of 224 cases from January 2014 to December 2021 were included. Following preoperative coronary artery CTA, preoperative coronary artery treatment or intraoperative adjunctive therapy (temporary transcutaneous cardiac pacemaker [TTCP] or intra-aortic balloon pumping [IABP]) was performed based on the degree of stenosis. We analyzed the outcomes of patients treated with CAS under this strategy at our institution.</p><p><strong>Results: </strong>Coronary artery disease was detected preoperatively in 143 cases (64%), with 91 cases (41%) indicated for coronary revascularization. Preoperative coronary artery treatment was performed in 76 cases (34%) prior to CAS, and adjunctive therapy with TTCP or IABP was provided in 28 cases (13%) during the procedure. No case developed perioperative coronary ischemic complication.</p><p><strong>Conclusion: </strong>In patients who have undergone CAS, perioperative coronary ischemic complications might be reduced by evaluating the risk of ischemic heart disease preoperatively, performing pre-CAS coronary artery intervention based on the severity of the lesions, and administering intraoperative adjunctive therapy.</p>","PeriodicalId":73856,"journal":{"name":"Journal of neuroendovascular therapy","volume":"18 5","pages":"131-136"},"PeriodicalIF":0.0000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11129055/pdf/","citationCount":"0","resultStr":"{\"title\":\"Preventive Strategies for Perioperative Ischemic Heart Disease during Carotid Artery Stenting.\",\"authors\":\"Shinya Fukuta, Mitsuhiro Iwasaki, Hidekazu Yamazaki, Masahiro Maeda, Masaki Koh, Yasufumi Inaka, Hiroaki Sato, Taichiro Hayase, Masafumi Morimoto\",\"doi\":\"10.5797/jnet.oa.2023-0062\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objectives: </strong>We have been performing preoperative coronary artery assessments and implementing coronary revascularization or intraoperative adjunctive therapies as needed in patients scheduled for carotid artery stenting (CAS) to prevent ischemic heart disease. In this study, we report the results of a retrospective observation of patients who underwent CAS under our treatment strategy to prevent perioperative coronary ischemic complications.</p><p><strong>Methods: </strong>A total of 224 cases from January 2014 to December 2021 were included. Following preoperative coronary artery CTA, preoperative coronary artery treatment or intraoperative adjunctive therapy (temporary transcutaneous cardiac pacemaker [TTCP] or intra-aortic balloon pumping [IABP]) was performed based on the degree of stenosis. We analyzed the outcomes of patients treated with CAS under this strategy at our institution.</p><p><strong>Results: </strong>Coronary artery disease was detected preoperatively in 143 cases (64%), with 91 cases (41%) indicated for coronary revascularization. Preoperative coronary artery treatment was performed in 76 cases (34%) prior to CAS, and adjunctive therapy with TTCP or IABP was provided in 28 cases (13%) during the procedure. No case developed perioperative coronary ischemic complication.</p><p><strong>Conclusion: </strong>In patients who have undergone CAS, perioperative coronary ischemic complications might be reduced by evaluating the risk of ischemic heart disease preoperatively, performing pre-CAS coronary artery intervention based on the severity of the lesions, and administering intraoperative adjunctive therapy.</p>\",\"PeriodicalId\":73856,\"journal\":{\"name\":\"Journal of neuroendovascular therapy\",\"volume\":\"18 5\",\"pages\":\"131-136\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11129055/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of neuroendovascular therapy\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5797/jnet.oa.2023-0062\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/3/23 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of neuroendovascular therapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5797/jnet.oa.2023-0062","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/3/23 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
目的:我们一直在对计划接受颈动脉支架植入术(CAS)的患者进行术前冠状动脉评估,并根据需要实施冠状动脉血运重建或术中辅助治疗,以预防缺血性心脏病。在本研究中,我们报告了对在我们的治疗策略下接受 CAS 的患者进行回顾性观察的结果,以预防围手术期冠状动脉缺血性并发症:方法:共纳入 2014 年 1 月至 2021 年 12 月的 224 例患者。术前冠状动脉CTA检查后,根据狭窄程度进行术前冠状动脉治疗或术中辅助治疗(临时经皮心脏起搏器[TTCP]或主动脉内球囊反搏[IABP])。我们分析了本院在此策略下接受 CAS 治疗的患者的疗效:结果:143 例(64%)患者术前发现冠状动脉疾病,其中 91 例(41%)有冠状动脉血运重建指征。76例患者(34%)在CAS术前进行了冠状动脉治疗,28例患者(13%)在术中进行了TTCP或IABP辅助治疗。没有一例患者在围手术期出现冠状动脉缺血并发症:结论:对于接受 CAS 手术的患者,通过术前评估缺血性心脏病的风险、根据病变的严重程度在 CAS 术前进行冠状动脉介入治疗以及术中进行辅助治疗,可以减少围术期冠状动脉缺血并发症的发生。
Preventive Strategies for Perioperative Ischemic Heart Disease during Carotid Artery Stenting.
Objectives: We have been performing preoperative coronary artery assessments and implementing coronary revascularization or intraoperative adjunctive therapies as needed in patients scheduled for carotid artery stenting (CAS) to prevent ischemic heart disease. In this study, we report the results of a retrospective observation of patients who underwent CAS under our treatment strategy to prevent perioperative coronary ischemic complications.
Methods: A total of 224 cases from January 2014 to December 2021 were included. Following preoperative coronary artery CTA, preoperative coronary artery treatment or intraoperative adjunctive therapy (temporary transcutaneous cardiac pacemaker [TTCP] or intra-aortic balloon pumping [IABP]) was performed based on the degree of stenosis. We analyzed the outcomes of patients treated with CAS under this strategy at our institution.
Results: Coronary artery disease was detected preoperatively in 143 cases (64%), with 91 cases (41%) indicated for coronary revascularization. Preoperative coronary artery treatment was performed in 76 cases (34%) prior to CAS, and adjunctive therapy with TTCP or IABP was provided in 28 cases (13%) during the procedure. No case developed perioperative coronary ischemic complication.
Conclusion: In patients who have undergone CAS, perioperative coronary ischemic complications might be reduced by evaluating the risk of ischemic heart disease preoperatively, performing pre-CAS coronary artery intervention based on the severity of the lesions, and administering intraoperative adjunctive therapy.